文献速递瓣膜外科先天性心脏病外科

ADAPT处理心包用于先天性心脏病主动脉瓣重建:人源植入物的组织学分析

ADAPT-treated pericardium for aortic valve reconstruction in congenital heart disease: histological analysis of a series of human explants.
PubMed 文献 · Eur J Cardiothorac Surg · 2019-01-01

本研究对12例先天性主动脉瓣疾病患儿植入的CardioCel补片(ADAPT处理牛心包)进行组织学分析,植入中位时间25个月。

要点

  • 所有CardioCel补片均见表面内皮化和补片上方纤维增生。
  • 植入≥23个月的标本多数出现钙化(G1-G3)。
  • 仅短植入时间(11和20个月)的2例未见钙化。

核心结论

  • 在本队列中,用于先天性心脏病主动脉瓣修复的CardioCel补片均表现出成纤维细胞和细胞外基质沉积,且植入至少23个月后出现钙化。

研究设计与样本

  • 对12例取出的主动脉瓣叶标本(11例手术取出,1例尸检)进行组织学分析,植入中位时间25个月(范围11-47个月)。

主要发现

  • 免疫组化显示所有患者均有表面内皮化。
  • 9例标本轻度炎症细胞浸润(G1),3例中度(G2)。
  • 所有标本均见补片上方显著增生(G1:1例;G2:7例;G3:4例)。
  • 2例植入时间最短(11和20个月)者无钙化(G0)。

临床怎么用

  • CardioCel补片用于儿童主动脉瓣修复时需关注远期钙化风险,尤其植入超过23个月者。

局限性

  • 样本量小(12例),为回顾性描述性研究,缺乏对照。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Different types of patch materials are used for aortic valve repair in children with congenital aortic valve disease to avoid early valve replacement. CardioCel© (Admedus, Toowong, QLD, Australia) consists of bovine pericardium treated with the ADAPT method (Admedus' proprietary tissue engineering process). METHODS: Our goal was to describe tissue reactions in 12 explanted aortic valve leaflet specimens (augmented or replaced with CardioCel patch material) (11 explanted surgically, 1 autopsy). Explantation was performed during reoperation after aortic valve repair, necessitated by aortic valve stenosis in 5, aortic valve insufficiency in 2, combined aortic valve lesions in 3 patients and endocarditis in 1 patient. One patient died of sudden left heart failure 28 months after aortic valve repair. At the last documented follow-up of this patient at 22 months, he showed mild aortic valve stenosis and insufficiency. Implantation time (time between implantation and explantation) of CardioCel patches was a median of 25 (range 11-47) months. Explants were examined using a uniform protocol with methylmethacrylate and/or paraffin embedding after fixation in formalin. Besides standard histological staining, von Kossa (for identification of calcifications) and immunohistochemical stains were applied with antibodies specific for muscular, inflammatory and connective tissue component antigens. Findings regarding the extent of appositional growth on top of the patch consisting of fibroblasts and extracellular matrix components, calcification, and inflammation were rated using a 4-grade scale (G0 no/G1 few/G2 moderate/G3 massive). RESULTS: Superficial endothelialization was demonstrated in all patients by immunohistochemical analysis. Nine specimens showed mild inflammatory cell infiltration (G1) (G2: n = 3). Significant appositional growth on top of the patch due to addition of fibroblasts and extracellular matrix components, was seen in all specimens (G1: n = 1; G2: n = 7; G3: n = 4). Ten of 12 samples with implant times of 23 months or longer revealed calcifications (G1: n = 6; G2: n = 3; G3: n = 1). Two specimens with the shortest implant times (11 and 20 months) showed no calcifications (G0). Thrombus apposition with granulocyte infiltration was demonstrated in the specimen of the patient with endocarditis. CONCLUSIONS: In our cohort, all CardioCel patches used for aortic valve repair in patients with congenital heart disease demonstrated appositional growth of fibroblasts and extracellular matrix components, and calcification after an implant time of at least 23 months.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Nordmeyer S, Kretzschmar J, Murin P, et al. ADAPT-treated pericardium for aortic valve reconstruction in congenital heart disease: histological analysis of a series of human explants. Eur J Cardiothorac Surg. 2019. PMID: 31504392. doi:10.1093/ejcts/ezz228

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。